🇺🇸 FDA
Patent

US 11813241

Multi-arm polymeric prodrug conjugates of taxane-based compounds

granted A61KA61K31/337A61K47/60

Quick answer

US patent 11813241 (Multi-arm polymeric prodrug conjugates of taxane-based compounds) held by Nektar Therapeutics expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/337, A61K47/60, A61P, A61P35/00